Article

The role of the killer immunoglobulin-like receptor in haematological malignancies and stem cell transplantation

2014-01-01

Abstract excerpt

Natural killer cells (NK) cells are marrow-derived cytotoxic lymphocytes, representing 5-18% of human blood mononuclear cells. NK cells are an important component of the innate immune system in humans playing important roles in both the elimination and control of tumour metastases and leukaemia. NK activity against target cells is determined, by the net balance of the transmitted intracellular signals from both ac...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: bd486f93-2061-54b9-bbba-4ac030ce5429
DOI: 10.25560/24660

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

The role of the killer immunoglobulin-like receptor in haematological malignancies and stem cell transplantationDOI 10.25560/24660Read

Killer Ig-Like Receptors (KIRs): Their Role in NK Cell Modulation and Developments Leading to Their Clinical ExploitationSemantic proximity Read

Killer-cell immunoglobulin-like receptor genes and ligands and their role in hematologic malignancies.Semantic proximity Read

Role of natural killer cells and killer immunoglobulin-like receptor polymorphisms: association of HLA and KIRs.Semantic proximity Read

Overview of the killer cell immunoglobulin-like receptor system.Semantic proximity Read

Natural killer cell receptors and ligand variants modulate response to tyrosine kinase inhibitors in patients with chronic myeloid leukemia.Semantic proximity Read

KIR Receptors as Key Regulators of NK Cells Activity in Health and DiseaseSemantic proximity Read

Killer immunoglobulin-like receptors (KIR2DL2 and/or KIR2DS2) in presence of their ligand (HLA-C1 group) protect against chronic myeloid leukaemia.Semantic proximity Read

Natural killer cells and acute myeloid leukaemiaSemantic proximity Read

KIR2DS1 genotype predicts for complete cytogenetic response and survival in newly diagnosed chronic myeloid leukemia patients treated with imatinib.Semantic proximity Read

Allelic polymorphisms of KIRs and antitumor immunity against chronic myeloid leukemia.Semantic proximity Read

Allelic Polymorphisms of KIRs and HLAs Predict Favorable Responses to Tyrosine Kinase Inhibitors in CML.Semantic proximity Read

Human NK receptors: From the molecules to the therapy of high risk leukemiasSemantic proximity Read